FireEye Stock Sees Flood of Options Bulls

FEYE has been steadily rising on the charts since March

by Laura McCandless

Published on May 22, 2020 at 3:30 PM

The shares of FireEye Inc (NASDAQ:FEYE) are up 3.2% at $11.84 at last check. Steadily rising on the charts since a record low of $7.54 on March 17, the software company has gained support at the 30-day moving average as it struggles to topple the $12 region. In the last monthly period, FEYE sports an 11.4% gain. 

FEYE may 22

Options players are betting on further upside today for FEYE as well, with 52,000 calls across the tape so far, compared to 1,700 puts -- two times the usual daily volume. Most popular by far is the weekly 5/29 12-strike call, where new positions are being opened, followed by the 11.5 call in the same series, which also happens to be the top open interest position.

Echoing this, in the past 10 days, 28.34 calls have been bought for every put at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which sits higher than 83% of readings from the past year.

Despite this, and the stock eyeing its second monthly win, short interest has spiked 52% in the last two reporting periods to 13.25 million shares. These pessimistic positions make up 6.2% of the stock's available float and would take nearly three days to cover at FEYE's average pace of trading. 

Analyst sentiment is mixed, with eight out of 15 analysts in coverage sporting a "buy" or better, and the remaining seven at a lukewarm "hold" rating. Meanwhile, the 12-month consensus target price of $13.79 is a 16.2% premium to current levels.


A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.